Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001628280-15-001687
Filing Date
2015-03-11
Accepted
2015-03-11 16:39:57
Documents
14
Period of Report
2014-12-31

Document Format Files

Seq Description Document Type Size
1 10-K mrtx-20141231x10k.htm 10-K 1680585
2 EXHIBIT 10.22 mrtx-20141231xex1022christ.htm EX-10.22 21298
3 EXHIBIT 23.1 mrtx-20141231xex231.htm EX-23.1 4992
4 EXHIBIT 23.2 mrtx-20141231xex232.htm EX-23.2 4957
5 EXHIBIT 31.1 mrtx-20141231xex311.htm EX-31.1 12411
6 EXHIBIT 31.2 mrtx-20141231xex312.htm EX-31.2 13454
7 EXHIBIT 32.1 mrtx-20141231xex321.htm EX-32.1 7919
14 GRAPHIC performancegraph.jpg GRAPHIC 42321
  Complete submission text file 0001628280-15-001687.txt   10064897

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT mrtx-20141231.xml EX-101.INS 1594924
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mrtx-20141231.xsd EX-101.SCH 52805
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT mrtx-20141231_cal.xml EX-101.CAL 77961
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT mrtx-20141231_def.xml EX-101.DEF 195448
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mrtx-20141231_lab.xml EX-101.LAB 691471
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mrtx-20141231_pre.xml EX-101.PRE 366094
Mailing Address 9363 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121
Business Address 9363 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121 (514) 337-3333
Mirati Therapeutics, Inc. (Filer) CIK: 0001576263 (see all company filings)

EIN.: 462693615 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-35921 | Film No.: 15693221
SIC: 2834 Pharmaceutical Preparations